Literature DB >> 9501223

Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance.

M J Tikkanen1, K Wähälä, S Ojala, V Vihma, H Adlercreutz.   

Abstract

The oxidation of low density lipoproteins (LDLs) is thought to take place in the arterial intima when the particles have become isolated from circulating water-soluble antioxidants. We hypothesized that isoflavonoid antioxidants derived from soy could be incorporated into lipoproteins and possibly could protect them against oxidation, which is regarded as atherogenic. Six healthy volunteers received 3 soy bars [containing the isoflavonoid antioxidants genistein (12 mg) and daidzein (7 mg)] daily for 2 weeks. LDLs were isolated from blood drawn at the the end of a 2-week dietary baseline period, after 2 weeks on soy, and after discontinuation of soy. Large increases in plasma isoflavonoid levels occurred during soy feeding, but only minute amounts were stably associated with lipoproteins (less than 1% of plasma isoflavonoids in the LDL fraction). The LDLs were subjected to copper-mediated oxidation in vitro. Compared with off soy values, lag phases of LDL oxidation curves were prolonged by a mean of 20 min (P < 0.02) during soy intake, indicating a reduced susceptibility to oxidation. The results suggest that intake of soy-derived antioxidants, such as genistein and daidzein, may provide protection against oxidative modification of LDL. As only very small amounts of these substances were detected in purified LDL, modified LDL particles may have been produced in vivo by circulating isoflavonoids promoting resistance to oxidation ex vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9501223      PMCID: PMC19702          DOI: 10.1073/pnas.95.6.3106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

Review 1.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

2.  Estrogenic soybean isoflavones and chronic disease Risks and benefits.

Authors:  T B Clarkson; M S Anthony; C L Hughes
Journal:  Trends Endocrinol Metab       Date:  1995 Jan-Feb       Impact factor: 12.015

3.  Monoclonal antibody-based immunoassay for evaluation of lipoprotein oxidation.

Authors:  S Preobrazhensky; I Trakht; V Chestkov; M Wentz
Journal:  Anal Biochem       Date:  1995-05-01       Impact factor: 3.365

4.  Effect of estrogen on the size of low-density lipoprotein particles in postmenopausal women.

Authors:  A Wakatsuki; N Ikenoue; Y Sagara
Journal:  Obstet Gynecol       Date:  1997-07       Impact factor: 7.661

5.  Anti-atherogenicity of soybean protein.

Authors:  T Kanazawa; M Tanaka; T Uemura; T Osanai; K Onodera; K Okubo; H Metoki; Y Oike
Journal:  Ann N Y Acad Sci       Date:  1993-03-15       Impact factor: 5.691

6.  Estradiol fatty acid esters occur naturally in human blood.

Authors:  L Janocko; R B Hochberg
Journal:  Science       Date:  1983-12-23       Impact factor: 47.728

7.  Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions.

Authors:  J K Lang; K Gohil; L Packer
Journal:  Anal Biochem       Date:  1986-08-15       Impact factor: 3.365

8.  Meta-analysis of the effects of soy protein intake on serum lipids.

Authors:  J W Anderson; B M Johnstone; M E Cook-Newell
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

9.  Serum and muscle tissue ubiquinone levels in healthy subjects.

Authors:  R Laaksonen; A Riihimäki; J Laitila; K Mårtensson; M J Tikkanen; J J Himberg
Journal:  J Lab Clin Med       Date:  1995-04

Review 10.  Soybean phytoestrogen intake and cancer risk.

Authors:  C H Adlercreutz; B R Goldin; S L Gorbach; K A Höckerstedt; S Watanabe; E K Hämäläinen; M H Markkanen; T H Mäkelä; K T Wähälä; T Adlercreutz
Journal:  J Nutr       Date:  1995-03       Impact factor: 4.798

View more
  39 in total

Review 1.  Effects of dietary animal and soy protein on cardiovascular disease risk factors.

Authors:  K D Hecker
Journal:  Curr Atheroscler Rep       Date:  2001-11       Impact factor: 5.113

2.  Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer.

Authors:  Iftekhar U Ahmad; Jeffrey D Forman; Fazlul H Sarkar; Gilda G Hillman; Elisabeth Heath; Ulka Vaishampayan; Michael L Cher; Fundagul Andic; Peter J Rossi; Omer Kucuk
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

3.  Impact of food matrix on isoflavone metabolism and cardiovascular biomarkers in adults with hypercholesterolemia.

Authors:  Jennifer Ahn-Jarvis; Steven K Clinton; Kenneth M Riedl; Yael Vodovotz; Steven J Schwartz
Journal:  Food Funct       Date:  2012-06-27       Impact factor: 5.396

4.  Antioxidant activity of various teas against free radicals and LDL oxidation.

Authors:  Reiko Ohmori; Tamami Iwamoto; Motomi Tago; Tadakazu Takeo; Tomonori Unno; Hiroshige Itakura; Kazuo Kondo
Journal:  Lipids       Date:  2005-08       Impact factor: 1.880

Review 5.  Protein - Which is Best?

Authors:  Jay R Hoffman; Michael J Falvo
Journal:  J Sports Sci Med       Date:  2004-09-01       Impact factor: 2.988

Review 6.  Role of phytoestrogens in prevention and management of type 2 diabetes.

Authors:  Mohammad Talaei; An Pan
Journal:  World J Diabetes       Date:  2015-03-15

7.  Genistein protects primary cortical neurons from iron-induced lipid peroxidation.

Authors:  Kwok Ping Ho; Lin Li; Li Zhao; Zhong Ming Qian
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

8.  Intake of dietary phytoestrogen and indices of antioxidant and bone metabolism of pre- and post-menopausal Korean women.

Authors:  Jeong-Hee Jang; Ji-Young Yoon; Sung-Hee Cho
Journal:  Nutr Res Pract       Date:  2007-12-31       Impact factor: 1.926

9.  Supplementary health benefits of soy aglycons of isoflavone by improvement of serum biochemical attributes, enhancement of liver antioxidative capacities and protection of vaginal epithelium of ovariectomized rats.

Authors:  Tu-Fa Lien; Yu-Lin Hsu; Dan-Yuan Lo; Robin Yy Chiou
Journal:  Nutr Metab (Lond)       Date:  2009-04-09       Impact factor: 4.169

10.  Increased NO bioavailability in aging male rats by genistein and exercise training: using 4, 5-diaminofluorescein diacetate.

Authors:  Sukanya Eksakulkla; Daroonwan Suksom; Prasong Siriviriyakul; Suthiluk Patumraj
Journal:  Reprod Biol Endocrinol       Date:  2009-09-07       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.